life
expect
increas
global
past
two
centuri
almost
year
last
five
decad
almost
year
recent
phenomenon
emerg
consequ
improv
nutrit
hygien
antimicrobi
therapi
vaccin
develop
antivir
therapi
howev
lag
behind
elderli
respiratori
viral
infect
still
caus
signific
morbid
mortal
nonpneumon
lower
respiratori
ill
link
respiratori
viral
infect
usa
alon
estim
annual
death
attribut
influenza
respiratori
syncyti
virus
rsv
mileston
diagnost
respiratori
viral
infect
discoveri
influenza
viru
discoveri
coronavirus
new
respiratori
virus
signific
viru
strain
identifi
year
develop
polymeras
chain
reaction
pcr
techniqu
initi
new
wave
viral
diagnost
first
avian
flu
epidem
human
caus
influenza
viru
struck
alert
healthcar
profession
sever
year
viru
famili
never
seen
human
identifi
anelloviru
torqu
teno
viru
ttv
signatur
viru
found
link
human
ill
clarifi
human
metapneumoviru
mpv
found
follow
discoveri
new
signific
respiratori
virus
viru
strain
coronavirus
sar
human
bocaviru
hbov
new
human
rhinoviru
hrv
strain
hrvc
hrvd
influenza
viru
potenti
respiratori
pathogen
polyomavirus
ki
wu
review
introduc
new
virus
review
clinic
signific
especi
regard
elderli
popul
made
systemat
search
pubm
data
base
articl
publish
march
index
follow
search
term
elderli
influenza
viru
influenza
viru
metapneumoviru
coronaviru
sar
bocaviru
rhinoviru
c
polyomaviru
ki
wu
torqu
teno
viru
review
articl
publish
english
sever
epidem
caus
influenza
viru
viru
pandem
result
estim
million
death
mortal
surprisingli
high
among
young
adult
recent
pandem
usual
caus
influenza
viru
strain
viru
highli
contagi
human
human
usa
preval
death
death
per
popul
occur
person
age
year
similarli
sourc
bird
infect
human
sinc
march
associ
high
mortal
patient
confirm
diseas
die
mortal
rate
associ
infect
among
children
age
year
elderli
often
protect
preexist
antibodi
previou
ill
mayb
even
decad
back
hand
risk
sever
ill
markedli
increas
underli
medic
condit
especi
chronic
obstruct
pulmonari
diseas
immunosuppress
diabet
obes
chronic
heart
condit
often
accompani
old
age
influenza
virus
typic
caus
midwint
epidem
typic
respiratori
symptom
cough
fever
sore
throat
howev
poorli
associ
confirm
influenza
ill
older
adult
hypoxia
chest
radiograph
consist
acut
respiratori
distress
syndrom
characterist
patient
requir
intens
care
death
occur
follow
approxim
one
week
onset
symptom
mortal
correl
high
viru
titer
caus
death
usual
progress
cardiopulmonari
failur
influenzarel
morbid
elderli
close
relat
preval
influenza
viru
infect
among
children
reservoir
diagnosi
mainli
base
antigen
detect
pcr
respiratori
specimen
cultur
serolog
also
avail
treatment
option
neuraminidas
inhibitor
oseltamivir
zanamivir
adamantan
deriv
amantadin
rimantadin
system
corticosteroid
effect
may
fact
increas
risk
hospitalacquir
pneumonia
superinfect
strainspecif
influenza
vaccin
usual
avail
month
emerg
pandem
usual
high
immunogen
among
elderli
subject
human
metapneumoviru
mpv
caus
upper
lower
respiratori
infect
patient
age
mostli
children
age
less
year
healthi
elderli
subject
mpvinfect
rare
one
larg
studi
show
mpv
rna
nasal
specimen
symptomat
asymptomat
elderli
subject
anoth
studi
mpv
found
patient
acut
exacerb
chronic
obstruct
pulmonari
diseas
copd
preval
symptomat
mpv
infect
higher
resid
longterm
care
facil
outbreak
elderli
institution
person
may
fall
ill
may
develop
radiograph
confirm
pneumonia
may
die
adult
elderli
mpv
typic
caus
influenzalik
symptom
rhiniti
cough
sore
throat
elderli
subject
prone
lower
respiratori
symptom
wheez
dyspnea
overal
elderli
mpv
infect
like
less
sever
rsv
infect
influenza
risk
factor
sever
ill
addit
old
age
institution
includ
immunosuppress
chronic
cardiopulmonari
ill
mpv
usual
caus
midwint
epidem
asymptomat
mpv
infect
rare
seem
two
propos
genotyp
b
sever
subgenotyp
mpv
thu
unlik
infect
either
genotyp
mpv
confer
crossprotect
immun
diagnosi
mpv
infect
base
pcr
immun
fluoresc
assay
also
avail
sever
vaccin
candid
investig
pandem
caus
sarscov
sar
sever
acut
respiratori
syndrom
initi
novemb
guangdong
provinc
china
affect
patient
caus
approxim
death
age
contin
approxim
month
period
infect
sarscov
almost
exclus
symptomat
resembl
influenza
initi
symptom
fever
myalgia
malais
chill
rigor
cough
common
dyspnea
promin
later
cours
ill
death
usual
due
respiratori
failur
sepsisrel
syndrom
advanc
age
comorbid
increas
markedli
risk
sever
ill
pcr
test
rapidli
develop
serolog
also
avail
effect
treatment
avail
interferon
ribavirin
seem
inhibit
viru
replic
sinc
inflamm
part
pathogenesi
diseas
corticosteroid
may
also
help
combin
antivir
medic
sever
new
antivir
vaccin
candid
investig
addit
coronavirus
new
coronavirus
identifi
sampl
patient
respiratori
symptom
like
coronavirus
detect
small
percentag
individu
age
virus
primarili
associ
mild
upper
respiratori
tract
infect
sever
lower
respiratori
tract
infect
also
report
diarrhea
abdomin
pain
may
also
occur
symptom
sign
relat
primarili
respiratori
tract
chronic
underli
condit
advanc
age
increas
suscept
diseas
sever
cov
infect
mortal
occur
studi
communityacquir
pneumonia
patient
old
median
age
year
signific
underli
diseas
especi
respiratori
cardiovascular
system
one
studi
report
outbreak
acut
respiratori
infect
personalcar
home
cov
identifi
patient
age
year
one
elderli
patient
die
day
onset
infect
distribut
throughout
globe
throughout
year
although
usual
peak
winter
time
caus
irregular
epidem
everi
year
sinc
virus
difficult
cultur
diagnost
test
pcr
avail
neither
specif
antivir
therapi
vaccin
avail
hcov
infect
preval
hbov
dna
respiratori
specimen
rang
typic
age
primari
hbov
infect
month
hbov
occur
world
wide
throughout
year
hbov
associ
upper
lower
respiratori
tract
infect
children
littl
known
hbov
infect
among
elderli
peopl
hbov
also
detect
fece
small
children
without
gastrointestin
respiratori
symptom
well
river
sewag
water
whether
true
enter
pathogen
known
although
hbov
infect
usual
diagnos
pcr
serolog
studi
shown
mere
presenc
hbov
dna
respiratori
tract
proof
acut
primari
hbov
infect
studi
consecut
npa
sampl
inde
shown
hbov
dna
persist
nasopharynx
sever
month
among
adult
antibodi
hbov
indic
encount
viru
live
preval
figur
high
show
hbov
infect
extrem
common
limit
number
hbov
dnaposit
adult
report
mainli
among
immunosuppress
subject
observ
line
high
seropreval
hbov
age
pattern
howev
interestingli
contradict
canadian
studi
find
differ
preval
hbov
among
differ
age
group
adult
hbovdna
posit
seem
associ
symptom
therefor
hbov
consid
simpli
innoc
bystand
viru
sinc
discoveri
hbov
three
relat
bocavirus
identifi
human
stool
sampl
human
rhinoviru
common
cold
viru
common
respiratori
pathogen
age
group
two
last
decad
last
millennium
thought
two
major
genet
group
b
hrv
serotyp
exist
novel
pcrbase
techniqu
howev
identifi
addit
two
group
c
possibl
differ
hrv
strain
moreov
pcr
markedli
increas
detect
rate
hrv
infect
hrvinfect
often
associ
pulmonari
morbid
common
viru
associ
exacerb
asthma
age
copd
adult
elderli
longterm
care
facil
hrv
may
caus
seriou
morbid
mortal
goe
often
unrecogn
louie
et
al
report
epidem
respiratori
ill
longterm
care
facil
caus
mortal
rate
affect
resid
die
seven
respiratori
specimen
cultureposit
rhinoviru
hick
et
al
report
two
nurs
home
outbreak
respiratori
ill
caus
death
resid
collect
sampl
posit
rhinoviru
overal
pauciti
data
hrvinfect
elderli
rhinoviru
may
except
instanc
caus
chronic
lung
infect
may
durat
month
prolong
infect
may
occur
immunocomprom
subject
lung
transplant
hypogammaglobulinemia
recent
identifi
group
c
hrv
appear
relat
high
morbid
viru
circul
rate
similar
hrva
b
group
caus
almost
half
hrvassoci
hospit
children
differ
hrv
strain
circul
commun
throughout
year
hrv
epidem
typic
peak
fall
spring
diagnosi
base
pcr
sinc
virus
difficult
cultur
serolog
feasibl
addit
previous
known
polyomavirus
bk
jc
seven
new
human
polyomavirus
identifi
rapid
sequenc
two
detect
respiratori
tract
sampl
name
institut
found
ki
karolinska
institut
polyomaviru
kipyv
wu
washington
univers
polyomaviru
wupyv
two
name
diseas
associ
detect
mcpyv
skin
cancer
call
merkelcel
carcinoma
tspyv
skin
diseas
call
trichodysplasia
spinulosa
remain
three
polyomavirus
also
detect
skin
sampl
name
number
preval
respiratori
ki
wupolyomavirus
patient
respiratori
symptom
patient
ki
wupyv
dna
upper
airway
young
children
symptom
rhiniti
cough
bronchiol
even
pneumonia
serolog
studi
show
seropreval
ki
wupyv
healthi
children
adult
data
occurr
virus
elderli
lack
urgent
need
sinc
pyv
potenti
oncogen
persist
human
tissu
ki
wupyv
becom
reactiv
similar
frequenc
bk
jc
virus
immunosuppress
diagnost
base
pcr
serolog
torqu
teno
viru
dna
recov
mani
tissu
secret
whether
observ
causal
relat
clinic
symptom
demonstr
ttv
possibl
abl
replic
airway
tissu
mani
tissu
eg
liver
bone
marrow
airway
might
primari
rout
transmiss
ttv
often
detect
blood
preval
ttv
dna
blood
healthi
individu
approxim
singl
ttv
infect
may
persist
year
caus
chronic
viremia
simultan
infect
differ
ttv
variant
may
also
occur
ttv
might
also
aggrav
symptom
caus
respiratori
virus
ttv
may
indic
diseas
process
impli
find
ttv
concentr
nasal
secret
plasma
posit
correl
marker
eosinophil
inflamm
neg
correl
pulmonari
function
asthma
also
sever
bronchiectasi
idiopath
pulmonari
fibrosi
correl
high
ttv
concentr
associ
ttv
diseas
could
base
direct
viral
effect
mediat
inflammatori
process
predispos
viru
replic
inde
ttv
replic
kinet
use
marker
immun
reconstitut
suppress
although
multipl
ttv
variant
caus
problem
detect
diagnosi
ttv
infect
base
pcr
serolog
appar
develop
near
futur
make
clinic
diagnosi
respiratori
viral
ill
elderli
patient
pose
challeng
clinic
pictur
much
blur
comparison
typic
upper
respiratori
infect
seen
children
young
adult
viral
infect
usual
due
reinfect
elderli
adult
usual
degre
immun
preexist
system
mucos
antibodi
elderli
adult
probabl
lower
amount
respiratori
secret
lower
viral
load
compar
children
among
elderli
patient
respiratori
viral
ill
may
accompani
symptom
lower
respiratori
tract
involv
pulmonari
cardiac
failur
nonspecif
atyp
symptom
confus
anorexia
dizzi
fall
lack
fever
final
elderli
may
also
unabl
articul
symptom
clearli
someth
common
infant
challeng
diagnost
viral
ill
optim
sampl
nasopharyng
swab
aspir
wash
tradit
use
children
well
toler
older
adult
older
peopl
best
way
time
take
sampl
viral
diagnost
known
elderli
although
nasopharyng
swab
sampl
sensit
suffici
method
children
simplest
sampl
method
may
difficult
appli
adult
obtain
suffici
sampl
viral
load
optim
sampl
probabl
requir
nasopharyng
oropharyng
sampl
take
swab
sampl
probabl
quickest
way
caus
least
discomfort
nasopharyng
wash
may
collect
virus
convent
diagnost
method
avail
new
respiratori
virus
serolog
avail
influenza
viru
mpv
hbov
pyv
howev
serolog
often
practic
acut
phase
convent
method
rapid
antigen
detect
test
avail
influenza
viru
report
suggest
rapid
antigen
detect
test
rel
sensit
detect
influenza
viru
elderli
patient
outbreak
detect
rapid
antigen
test
cultur
posit
sampl
studi
report
much
lower
sensit
compar
pcr
sensit
may
patient
year
age
despit
poor
sensit
rapid
antigen
detect
test
highli
specif
detect
influenza
virus
elderli
new
respiratori
virus
diagnos
sensit
pcr
method
diagnos
acut
hbov
sarscov
infect
pcr
need
complement
serolog
current
virus
respiratori
sampl
children
respiratori
symptom
may
detect
pcr
best
choic
also
elderli
sinc
sensit
method
detect
virus
age
group
well
although
detect
rate
probabl
due
difficulti
sampl
declin
age
detect
rate
among
elderli
patient
remain
even
exacerb
chronic
pulmonari
diseas
viral
pneumonia
rate
intermedi
age
group
ie
adult
exacerb
copd
asthma
actual
preval
new
virus
among
elderli
popul
known
interpret
posit
pcr
result
complic
multipl
coexist
virus
especi
symptomat
children
high
viru
detect
rate
asymptomat
subject
young
children
review
literatur
goe
back
stretch
preval
virus
sampl
asymptomat
subject
higher
pcr
convent
method
cast
doubt
clinic
signific
pcrposit
viral
find
overal
sever
studi
hand
demonstr
posit
pcr
result
clinic
relev
least
far
hrv
concern
identif
hrv
correl
respiratori
symptom
dual
hrv
infect
rare
overal
preval
recurr
persist
respiratori
viral
infect
exclud
ttv
hbov
low
posit
find
pcr
correl
system
local
immun
respons
children
adult
find
mainli
appli
hrv
hbov
suggest
hrvpcr
posit
probabl
reflect
true
current
respiratori
infect
without
symptom
rather
residu
nucleic
acid
distant
infect
cours
find
upper
airway
sampl
necessarili
reflect
situat
lower
airway
multipl
pcr
analys
singl
sampl
multiplex
pcr
may
sound
attract
sensit
identif
individu
virus
may
lost
compar
singl
viru
pcr
note
data
studi
children
adult
data
new
respiratori
virus
elderli
scarc
term
immunosenesc
describ
deleteri
ageassoci
chang
immun
system
render
elderli
individu
suscept
infecti
diseas
increas
morbid
mortal
age
compon
immun
affect
cell
suscept
although
adapt
function
immun
appear
serious
affect
innat
immun
system
increas
suscept
lower
respiratori
tract
viral
infect
relat
particularli
defect
innat
immun
weaken
immun
respons
could
link
overal
longterm
poor
outcom
elderli
immunosenesc
multifactori
process
associ
thymic
involut
chronic
antigen
stimul
predominantli
attribut
persist
infect
signal
transduct
chang
immun
cell
proteinenergi
malnutrit
pauciti
accur
data
link
caus
death
elderli
ageassoci
chang
immun
system
except
influenza
virus
specif
treatment
vaccin
avail
combat
new
virus
sens
clinic
need
viral
diagnosi
viral
detect
may
still
practic
import
regard
isol
practic
infect
patient
hospit
longterm
care
set
prevent
transmiss
diseas
proper
support
treatment
includ
avoid
unnecessari
antibiot
treatment
increas
suscept
viral
infect
could
marker
pulmonari
inflammatori
process
indic
need
intensifi
treatment
chronic
pulmonari
ill
exampl
ttv
adv
infect
associ
chronic
inflammatori
state
lung
children
link
suscept
hrvinduc
wheez
develop
asthma
adult
hrv
import
trigger
exacerb
copd
current
knowledg
bacterialvir
coinfect
elderli
limit
communityacquir
pneumonia
adult
evid
mix
viralbacteri
infect
case
children
case
frequent
combin
streptococcu
pneumonia
influenza
viru
hrv
bacteri
viral
infect
may
act
deleteri
synergist
mechan
may
destruct
respiratori
epithelium
viral
infect
may
increas
bacteri
adhes
virusinduc
immunosuppress
may
caus
bacteri
superinfect
inflammatori
respons
viral
infect
may
upregul
express
molecul
suitabl
bacteria
receptor
vaccin
develop
new
virus
promis
preclin
result
report
vaccin
candid
mpv
sarscov
efficaci
studi
human
new
respiratori
virus
viral
strain
includ
influenza
viru
mpv
sar
hbov
hrvc
possibl
respiratori
pathogen
ki
wupyv
ttv
new
virus
distribut
throughout
globe
affect
peopl
age
data
virus
elderli
scarc
new
viral
infect
diagnos
sensit
pcr
method
virus
may
detect
airway
vari
period
time
also
acut
phase
lead
diagnosi
sever
concomit
virus
classic
predispos
factor
viral
infect
includ
advanc
age
chronic
ill
poor
immun
respons
elderli
often
partial
immun
chronic
ill
circumst
modifi
respons
virus
thu
respiratori
viral
infect
may
manifest
atyp
symptom
exacerb
chronic
ill
seriou
outbreak
report
longterm
care
facil
vaccin
effect
way
prevent
seriou
diseas
avail
influenza
viru
virusspecif
treatment
also
avail
influenza
viru
earli
identif
viral
pathogen
improv
viral
diagnost
crucial
success
treatment
viral
ill
prevent
measur
also
import
vaccin
handwash
isol
affect
individu
hospit
longterm
care
facil
ultim
clinic
signific
new
respiratori
virus
still
poorli
unknown
elderli
popul
probabl
infect
greatli
underestim
